Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Operating activities:
Net loss	$ (8,502,410)	$ (20,266,534)
Adjustments to reconcile net loss from operations to net cash used in operating activities:
Depreciation and amortization	18,062	12,624
Bad debt	32,813
Stock and stock option compensation	1,760,621	4,225,686
Inducement of warrant exchange	650,616
Amortization of discounts and financing fees	429,731	2,447,608
Change in fair value of warrant derivative liabilities	1,680,246	8,546,411
Expense on issuance of derivative liabilities	604,504	1,283,103
Research and development	177,652
Loss on retirement of assets	37,544
Changes in operating assets and liabilities:
Inventory	1,335,306	(1,150,744)
Accounts receivable	9,959	(204,263)
Prepaid expenses and other assets	(104,903)	260,696
Accounts payable and accrued expenses	140,044	677,105
Net cash used in operating activities	(1,730,215)	(4,168,308)
Investing activities:
Additions to fixed assets		(66,063)
Intellectual property	(17,585)
Net cash used in investing activities	(17,585)	(66,063)
Financing activities:
Loan proceeds	1,835,000	2,291,000
Repayment of notes payable	(125,000)	(60,000)
Proceeds from warrant and option exercises	14,691	2,321,536
Net cash provided by investing activities	1,724,691	4,552,536
Net increase (decrease) in cash and cash equivalents	(23,109)	318,165
Cash and cash equivalents, beginning of period	29,430	62,050
Cash and cash equivalents, end of period	6,321	380,215
Non-cash investing and financing activities:
Common stock issued for convertible notes payable and accrued interest	252,272	2,356,207
Transfer from derivative liability to additional paid in capital	3,098,549	10,641,398
Discount on debt recorded as derivative liability	$ 1,275,309	$ 2,050,000